Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
6 participants
INTERVENTIONAL
2011-11-09
2012-04-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Acute Pain in Healthy Adults
NCT03985995
Effects of Smoked Marijuana on Neuropathic Pain
NCT00254761
The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome
NCT06393101
A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury
NCT01606202
Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy
NCT00781001
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
THC 0.01 mg/kg
Thermal
Thermal sensation/pain testing
Electrical
Electrical sensation/pain testing
Capsaicin
Intradermal Capsaicin
THC
Active THC (0.01 mg/kg) administered over 10 minutes
Placebo
Thermal
Thermal sensation/pain testing
Electrical
Electrical sensation/pain testing
Capsaicin
Intradermal Capsaicin
Placebo
Control: small amount of alcohol with no THC, administered over 10 minutes
THC 0.03 mg/kg
Thermal
Thermal sensation/pain testing
Electrical
Electrical sensation/pain testing
Capsaicin
Intradermal Capsaicin
THC
Active THC (0.03 mg/kg) administered over 10 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thermal
Thermal sensation/pain testing
Electrical
Electrical sensation/pain testing
Capsaicin
Intradermal Capsaicin
THC
Active THC (0.01 mg/kg) administered over 10 minutes
THC
Active THC (0.03 mg/kg) administered over 10 minutes
Placebo
Control: small amount of alcohol with no THC, administered over 10 minutes
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acceptable Birth Control methods for females
Exclusion Criteria
* Medical or psychiatric contraindications
* Analgesic medication
* Previous sensitivity to THC or cannabis
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Deepak C. D'Souza
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deepak C D'Souza, M.D.
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Connecticut Healthcare System
West Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1005006859
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.